References
- Amar L, Lepoutre C, Bobrie G, Plouin PF. Hypertension artérielle endocrine. Rev Med Interne. 2010;23(3):697-704. PubMed | Google Scholar
- Steichen O, Plouin PF. Prise en charge actuelle
de l'hypertension artérielle. Rev Med Interne. 2013; Volume 35(Issue
4):Pages 235-242. PubMed | Google
Scholar
- Maria Czarina Acelajado, David Calhoun A. Resistant hypertension, secondary hypertension, and hypertensive Crises: diagnostic evaluation and treatment. Cardiol Clin. 2010;28(4):639-654. PubMed | Google Scholar
- Amar L, Lorthioir A , Giavarini A, Plouin P, Azizi
M. Hypertension artérielle d'origine surrénale : reconnaître, évaluer
et prendre en charge. Presse Med. 2014;43(4):420-427. PubMed | Google
Scholar
- Sukor N. Endocrine hypertension - Current understanding and comprehensive management review. Eur J Intern Med. 2011;22(5):433-440. PubMed | Google Scholar
- Al-Salameh A, Cohen R, Chanson P, Plouin PF. Données récentes sur l'hypertension endocrine. Ann Endocrinol. 2012;73 (S2): 26-35. PubMed | Google Scholar
- Amar J. Quand et comment recherché une cause surrénalienne à une hypertension artérielle? Réalités Cardiologiques. 301Mai/Juin 2014. PubMed | Google Scholar
- Paul Stewart M. Endocrine hypertension. MEDICINE. 2013;41:9. PubMed | Google Scholar
- Plouin PF. Prevalence and etiologies of endocrine hypertension. Best Practice & Research Clinical Endocrinology & Metabolism. 2006;20(3):vii- viii. PubMed | Google Scholar
- Rory Mc Quillan F, Peter Conlon J. Secondary Hypertension. National Kidney Foundation Primer on Kidney Diseases 6th Revised edition. Google Scholar
- Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010;82(12):1471-1478. PubMed | Google Scholar
- Beltran S, Borson-Chazot F. Phéochromocytome. Emc
Endocrinologie - Nutrition Doi : 10.1016/S1155-1941(13)64274-2. PubMed | Google
Scholar
- Zuber SM, Kantorovich V, Pacak K. Hypertension in Pheochromocytoma: Characteristics and Treatment. Endocrinol Metab Clin North Am. 2011;40(2): 295-311. PubMed | Google Scholar
- Fountoulakis S, Tsatsoulis A. Molecular genetics aspects and pathophysiology of endocrine hypertension. Hormones. 2006;5(2);90:106. PubMed | Google Scholar
- Luca F et al. Manifestations cardiaques des phéochromocytomes. Ann Endocrinol. 2009;70(1):43-47. PubMed | Google Scholar
- Pogorzelski R. The effect of surgical treatment of pheochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study. Cent European J Urol. 2014;67(4):361-365. PubMed | Google Scholar
- Vesin C. Hypertensions artérielles secondaires d'origine surrénalienne: syndromes de Conn, de Cushing et autres entités. EMC Cardiologie. 2009:1-12 [Article 11-301-F-10]. PubMed | Google Scholar
- LeRoith D. Endocrine hypertension. Endocrinol Metab Clin N Am. 2011;40(2):xiii-xv. PubMed | Google Scholar
- Trifanescu R et al. Screening for Secondary Endocrine Hypertension in Young Patients. MAEDICA - a Journal of Clinical Medicine. 2013;8(2):108-115. PubMed | Google Scholar
- Christian Koch A. Endocrine hypertension: What is new? Rev Port Endocrinol Diabetes Metab. 2012;7(2):52-61. PubMed | Google Scholar
- David Weiner I. Endocrine and Hypertensive Disorders of Potassium Regulation: primary aldosteronism. Seminars in Nephrology. 2013;l33(3):265-276. PubMed | Google Scholar
- Maria Abad- Cardiel et al. Hypertension Caused by Primary Hyperaldosteronism: increased heart damage and cardiovascular risk. Rev Esp Cardiol. 2013;66(1):47-52. PubMed | Google Scholar
- Fedrizzi D et al. Hypertension-related factors in patients with active and inactive acromegaly. Arq Bras Endocrinol Metab. 2011; 55(7): 468-474. PubMed | Google Scholar
- Omura M. Prospective Study on the Prevalence of Secondary Hypertension among Hypertensive Patients Visiting a General Outpatient Clinic in Japan Hypertens Res. NCBI. 2004;27(3) 193-202. PubMed | Google Scholar